| 000 | 01069 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517020353.0 | ||
| 264 | 0 | _c20160906 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a2299-5684 | ||
| 024 | 7 |
_a10.1016/j.pharep.2014.09.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChandel, Shammy | |
| 245 | 0 | 0 |
_aCurrent scenario in inflammatory bowel disease: drug development prospects. _h[electronic resource] |
| 260 |
_bPharmacological reports : PR _cApr 2015 |
||
| 300 |
_a224-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 700 | 1 | _aPrakash, Ajay | |
| 700 | 1 | _aMedhi, Bikash | |
| 773 | 0 |
_tPharmacological reports : PR _gvol. 67 _gno. 2 _gp. 224-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharep.2014.09.005 _zAvailable from publisher's website |
| 999 |
_c24653076 _d24653076 |
||